NASDAQ : SVRA
Savara Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 4.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.22B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Details
| Name | Savara Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 70 |
| Founded | 2007 |
| Ceo | Matthew Pauls |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US8051111016 |
| Cusip | 805111101 |
| Cik | 0001160308 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Matthew Pauls J.D., M.B.A. | Chairman and Chief Executive Officer |
| Robert Matthew Lutz M.B.A. | Chief Operating Officer and Chief Financial Officer |
| Dr. Yasmine Wasfi M.D., Ph.D. | Chief Medical Officer |
| Kate McCabe J.D. | Chief Legal Officer |
| Megan Carpenter | Chief People Officer |
| Anne Erickson | Chief Business and Corporate Affairs Officer |
| Brian Maurer | Head of Clinical Operations |
| Charles LaPree | Executive Vice President and Head of Global Regulatory Affairs |
| Dr. Brian Robinson M.D. | Executive Vice President of Global Medical Affairs |
| Dr. Siddharth J. Advant Ph.D. | Executive Vice President of Global Technical Operations |
Contact
| Address | The Tannery Building, Suite 200, Yardley, Pennsylvania 19067, United States |
| Phone | (512) 614-1848 |
| Website | https://www.savarapharma.com |